baber/WOPTO huggingface dataset:
Patent MX-2010004300-A (MX)
Title: (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease.
Inventor: SCHUMACHER RICHARD
IPC: C07D453/00
Filed: 2008-10-22
Abstract: The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds, which act as ligands for the a7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof. The novel compounds include compounds of formula I: (I) wherein X, R1, and R2 are as herein defined.
Patent MX-2010005310-A (MX)
Title: Isocyanate terminated polytrimethylene ether polyol and process for making same.
Inventor: CORCORAN PATRICK HENRY
IPC: C09D175/08
Filed: 2008-11-13
Abstract: Polyethers of 1,3-propane diol are terminated with polyisocyanates. The isocyanate terminated polytrimethylene ether polyols provide crosslinking agents that provide coating compositions having short dry time, excellent appearance, and resistance to chipping damage.
Patent MX-2010005444-A (MX)
Title: Swallow-proof closing cap for containers, particularly food containers and particularly beverage bags.
Inventor: SCHWARTZ ERHARD
IPC: B65D50/00
Filed: 2010-05-18
Abstract: The present invention relates to a closing cap for containers, particularly food containers and particularly beverage bags. Since the closing cap according to the invention is designed as a wing cap that cannot be swallowed by infants, a potential health risk for children is minimized by the closing cap.
Patent MX-2010006731-A (MX)
Title: Use of a neurotoxic component of a clostridium botulinum toxin complex to reduce or prevent side effects.
Inventor: MARX MATTHIAS
IPC: A61K38/16
Filed: 2008-12-17
Abstract: Use of a neurotoxic component of a Clostridium botulinum toxin complex for the facial cosmetic treatment of a human or animal susceptible to suffering from doll's face or frozen face, or the neurotoxic component of a Clostridium botulinum toxin complex for the treatment of a disease or disorder caused by or associated with hyperactive cholinergic innervation of muscles or exocrine glands in a human or animal susceptible to side effects associated with the treatment of said disease or disorder with a Clostridium botulinum toxin complex.
Patent MX-2010007386-A (MX)
Title: Control channel signaling using code points for indicating the scheduling mode.
Inventor: WENGERTER CHRISTIAN
IPC: H04W72/04
Filed: 2008-11-18
Abstract: The invention relates to a control channel signal for use in a mobile communication system providing at least two different scheduling modes. Further the invention relates to a scheduling unit for generating the control channel signal and a base station comprising the scheduling unit. The invention also relates to the operation of a mobile station and a base station for implementing a scheduling mode using the control channel signal proposed by the invention. In order to facilitate the use of different scheduling schemes for user data transmission while avoiding an additional flag for indicating the scheduling mode in the control signaling, the invention proposes the use of code points in existing control channel signal fields. Further, the invention proposes a specific scheduling mode for use in combination with the proposed new control channel signal according to the invention. According to this scheduling mode control channel information is only provided for retransmissions, while initial transmissions are decoded using blind detection.
Patent MX-2010007488-A (MX)
Title: Process for obtaining a prebiotic product from agave fourcroydes.
Inventor: CURBELO YANELIS GARCA A
IPC: A23L33/00
Filed: 2010-07-07
Abstract: The present invention relates to the field of the animal diet, to the obtention of additives from plants, specifically to the obtention of a product with high fructanes levels and the application thereof as prebiotic upon achieving an enhanced growth of bacteria beneficial to the gastrointestinal tract (probiotic bacteria), which results in an improved health of the host. The purpose of the invention is to provide a process for obtaining a prebiotic product resulting from the Agave fourcroydes to be used as additive, which has high fructanes levels in polydisperse mixtures, in animal diets. The process consists in a plurality of extractions from the stem using deionized water, at a temperature of 500°C, where the liquid phases thus obtained are collected and filtered in order to reduce the volume thereof, finally being lyophilized and obtaining a solid product. The resulting product is a functional feed with a prebiotic effect, which stimulates the growth of bifidobacteria and lactobacilli in the gastrointestinal tract, thus reducing the pH and increasing the formation of fatty acids of short chain, which promotes a good health and productive behavior in the animal.
Patent MX-2010010284-A (MX)
Title: Uv light therapy delivery apparatus.
Inventor: THOMAS PEREZ
IPC: A61N5/06
Filed: 2009-05-15
Abstract: An light therapy apparatus is defined to include a UV light source secured to a casing. A shroud is placed over an exposed portion of the UV light source and is secured or attached around the perimeter of the casing end. Since the UV light source can generate a significant amount of heat, the casing includes an internal fan. Various tubing configurations may be used to help direct the air flow from the fan around the UV light source. In addition, a vent opening in the shroud was found to reduce the temperature of the shroud to prevent damage to a person's user the apparatus.
Patent MX-2010012985-A (MX)
Title: Mechanism of action of primary cell derived biologic.
Inventor: HADDEN JOHN W
IPC: A61K39/395
Filed: 2009-05-29
Abstract: A method of treating an immune target that is suppressing the immune system and restoring the immune system, including the steps of administering an effective amount of a primary cell derived biologic, modifying populations of B and T cells in blood, activating regional lymph nodes, infiltrating an area adjacent to an immune target with T helper and B cells, infiltrating the immune traget with T killer cells and macrophages, and treating the immune target and restoring the immune system. A method of inducing immunization in a patient. A method of destroying a tumor. A method of predicting a favorable treatment outcome to cancer treatment. A method of immune prophylaxis. A method of immune restoration. A method of treating a tumor. A method of preventing tumor escape.
Patent MX-2010012993-A (MX)
Title: Coating composition which adsorbs odourous and harmful substances and is intended for the box casting of metals.
Inventor: STOETZEL REINHARD
IPC: B22C9/04
Filed: 2009-05-27
Abstract: The invention relates to a casting mould for the casting of metals, wherein a layer consisting of a material which absorbs harmful substances is arranged on at least sections of gas outlet surfaces of the casting mould, in particular the top side thereof. The invention also relates to a coating composition, to a process for producing the casting mould and to the use thereof for the casting of metals.
Patent MX-2011005105-A (MX)
Title: Self-setting automatic slack adjuster with increased durability.
Inventor: LOUIS JOHN
IPC: F16D51/00
Filed: 2009-11-04
Abstract: An improved self-adjusting automatic slack adjuster for reducing slack in the brake of a vehicle, in which a one-way clutch assembly is arranged in the housing of the automatic slack adjuster housing such that a thin- wall region of the housing associated with the gear drive of the one-way clutch assembly is located outside of a load path through which brake applications forces are conveyed from a brake actuator to a brake cam shaft upon which the automatic slack adjuster is located. The new positioning of the one-way clutch assembly drive results in unexpectedly lower stress levels in the automatic slack adjuster, resulting a more durable slack adjuster and permitting surprisingly large increases in slack adjuster capacity rating.
Patent MX-2011005572-A (MX)
Title: Extrudate having spicular active substances.
Inventor: KANIKANTI VENKATA-RANGARAO
IPC: A23L27/30
Filed: 2009-11-24
Abstract: The invention relates to extrudates comprising at least one pharmaceutically active substance in the shape of pins, wherein the ratio of particle sizes of the spicular pharmaceutically active substance to the strand diameter is at least 1:15, and to the use of said extrudates for producing medications.
Patent MX-2011006721-A (MX)
Title: Pharmaceutical formulation of nanonised fenofibrate.
Inventor: OURY PASCAL
IPC: A61K9/20
Filed: 2009-12-24
Abstract: The invention relates to a pharmaceutical formulation of nanonised fenofibrate, to a method for preparing same, and to the uses thereof.
Patent MX-2011006770-A (MX)
Title: Method and system to distribute fault information in a large scale communication network system.
Inventor: POWER JOHN
IPC: H04L12/24
Filed: 2009-06-10
Abstract: The present invention relates to a method and an arrangement for distributing fault information from a lower level network management node (25, 28) to a higher level network management node (20) in a network management architecture comprising modules (28) logically representing network nodes and network links under management. The higher level network management node (20) subscribes to at least some detailed fault information. And, a notification comprising a summary of fault information sent by the lower level network management node (25) is received by the higher level network management node (20). Then, the higher level network management node (20) retrieves the subscribed detailed fault information from said received notification.
Patent MX-2011012760-A (MX)
Title: Engineered fibers for well treatments.
Inventor: LEE JESSE
IPC: E21B33/138
Filed: 2010-05-17
Abstract: Mixtures of fibers and solid particles are effective for curing fluid losses and lost circulation in a subterranean well. Stiff fibers are more effective than flexible ones; however, mixtures of stiff and flexible fibers have a synergistic effect. The quantity and particle-size distribution of the solids are optimized according to the stiffness, dimensions and concentrations of fibers.
Patent MX-2011013611-A (MX)
Title: Process for expanding perlite using microwaves as power source.
Inventor: GARIB JUAN ANTONIO AGUILAR
IPC: C04B26/00
Filed: 2011-12-15
Abstract: The present invention consists in a process for expanding particles of mineral perlite of different granulometries using microwaves as heating source. The process consists in locating a crucible that resists high temperatures and which contains graphite and the perlite; the crucible is placed in a specific place within a multimodal cavity, even though this may be placed in a resonant cavity or a wave guide. The sample is irradiated with microwaves and after a predetermined period of time the crucible being removed with the already expanded perlite. This process may be performed in batches or in a continuous mode, depending on the microwave applicator.
Patent MX-2012000760-A (MX)
Title: Process for the preparation of alkylphosphates.
Inventor: HANSEL JAN-GERD
IPC: C07F9/09
Filed: 2012-01-16
Abstract: Preparing tetraalkylbisphosphate (A) comprises (a) reacting a tetrachlorobisphosphate compound with one or more alcohol; (b) reacting the reaction mixture from the step (a) with a base containing one or more ionic substance (T), when in step (a), at least 50% of phosphorus-chloride groups contained in tetrachlorobisphosphate compound is converted; (c) precipitating at least a portion of the obtained cationic chloride salt (T1) as a solid; and (d) separating the solid from the mixture. Preparing tetraalkylbisphosphate (A) comprises (a) reacting a tetrachlorobisphosphate compound with one or more alcohol; (b) reacting the reaction mixture from the step (a) with a base containing one or more ionic substance of formula ((cat(n +>)) a(X(m ->)) b) (T), when in step (a), at least 50% of phosphorus-chloride groups contained in tetrachlorobisphosphate compound is converted; (c) precipitating at least a portion of the obtained cationic chloride salt of formula (catCl n) (T1) as a solid; and (d) separating the solid from the mixture. catn +> : a cation with a charge n; Xm -> : an anion with a charge m; and a, b : integers satisfying the relationship of nx a is equal to mx b.
Patent MX-2012001918-A (MX)
Title: Integrated vascular delivery system.
Inventor: WHITE STEVEN B
IPC: A61M5/162
Filed: 2010-08-13
Abstract: An integrated vascular delivery system having a frame configured to receive a catheter insertable in a patient to deliver fluid at an insertion site. The frame includes a first hub, a second hub, and a pair of flexible lateral members extending between the hubs and including a tubular lateral member. The system also includes a fluidic channel that fluidically communicates with the catheter, wherein the fluidic channel passes through the tubular lateral member and at least one of the hubs, and includes a fixed turnabout portion in which fluid flows in a direction different from that within the catheter. The first and second hubs provide anchoring points on the patient distributed around the insertion site and on opposite ends of the catheter, thereby anchoring the frame to the patient and stabilizing the catheter. A method is provided for using an integrated vascular delivery system.
Patent MX-2012002469-A (MX)
Title: Process for colour neutralizing compositions.
Inventor: LABEQUE REGINE
IPC: C11D11/00
Filed: 2010-07-29
Abstract: The present application relates to a process of colour neutralizing treatment liquids, wherein the treatment liquid comprises a chromophore selected from the group consisting of monoazo, triarylmethane, xanthene, anthraquinone, hydrophobic dyes, and mixtures thereof, wherein the hydrophobic dyes are selected from the group consisting of benzodifuranes; methine; triphenylmethanes; naphthalimides; pyrazole; naphthoquinone; mono-azo, di-azo dyes and mixtures thereof, said process comprising the steps of : i. providing a mixing vessel with the treatment composition comprising the chromophore; ii. providing to the mixing vessel more than 0.045% of a reducing agent selected from the group consisting of sulfite, thiodiurea, formaldehyde bisulfite formaldehyde sulfoxilate and mixtures thereof; and iii. mixing until discolouration by color neutralization of the chromophore is achieved.
Patent MX-2013004457-A (MX)
Title: Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system.
Inventor: LEHMANN LUTZ
IPC: C07B59/00
Filed: 2011-10-17
Abstract: This invention relates to novel compounds suitable as precursors for the preparation of certain 18F labelled positron emission tomography (PET) tracers. Furthermore, the invention relates to the preparation of such precursor molecules and to the preparation of PET tracers by 18F labelling of such precursors.
Patent MX-2013006178-A (MX)
Title: Laundry detergents.
Inventor: PANANDIKER RAJAN KESHAV
IPC: C11D1/02
Filed: 2011-12-09
Abstract: A laundry detergent comprises a granulated foam control composition and an anionic surfactant, wherein the granulated foam control composition comprises a foam control agent, an organic additive composition, a water soluble particulate carrier and a charged cationic polymer. The foam control agent comprises a polydiorganosiloxane fluid, a hydrophobic filler and optionally an organosilicone resin. A method of cleaning a fabric, a method of conserving water when washing fabric and a method of saving time when washing fabric are also disclosed.
Patent MX-2013006299-A (MX)
Title: Beverage products with non-nutritive sweetener and bitterant.
Inventor: LEE THOMAS
IPC: A23L27/30
Filed: 2010-12-06
Abstract: Aspects of the invention relate to beverage compositions, including, for example, concentrated and ready-to-drink formulations sweetened with at least one non-nutritive sweetener and further comprising a bitterant in an amount sufficient to reduce the lingering sweet aftertaste of the non-nutritive sweetener(s). In certain illustrative embodiments, the bitterant comprises gentian. Another aspect of the invention relates to a method that combines a non-nutritive sweetener having a lingering sweet aftertaste with a bitterant to create a mixture such that when the mixture is contained in a beverage, the bitterant is present in an amount sufficient to reduce the lingering sweet aftertaste of the non-nutritive sweetener.
Patent MX-2013006847-A (MX)
Title: Fused heterocyclic compound and use for pest control thereof.
Inventor: TAKYO HAYATO
IPC: A01N43/78
Filed: 2011-12-22
Abstract: A fused heterocyclic compound the formula (1) : wherein A1 represents -NR8-, and the like; A2 represents a nitrogen atom, and the like; A3 represents a nitrogen atom, and the like; R1 represents a C1-C6 chain hydrocarbon group optionally having one or more atoms or groups selected from Group X, and the like; R2, R3, R4, and R5 are same or different and represent independently a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, and the like; R6 and R7 are same or different and represent independently a C1-C6 chain hydrocarbon group optionally having one or more atoms or groups selected from Group X, and the like; R8 represents a C1-C6 chain hydrocarbon group optionally having one or more atoms or groups selected from Group W, and the like; n represents 0, 1 or 2. The compound has an excellent activity of controlling pests.
Patent MX-2013012925-A (MX)
Title: Methods and compositions for silencing gene families using artificial micrornas.
Inventor: MCGONIGLE BRIAN
IPC: C12N15/82
Filed: 2012-05-09
Abstract: Methods and compositions are provided which allow for a single microRNA (miRNA) to reduce the level of expression of at least two members of the same protein and/or gene family. While a single 21 base pair miRNA can cause cleavage of a variety of species of mRNAs, an entire gene family cannot be silenced unless that gene family shares near identity within a 21 base pair region that is also able to be cleaved by a single miRNA. In certain embodiments, all members of a given protein and/or gene family can be suppressed with a miRNA expression construct disclosed herein even if they do not share near identity within a 21 base pair region that is also able to function as a miRNA. Such methods and compositions employ miRNA expression constructs having a structure such that the most abundant form of miRNA produced from the construct is a 22-nucleotide miRNA. The 22-nucleotide miRNA produced from the miRNA expression construct thereby reduces the level of expression of not only the target sequence for the miRNA, but also reduces the level of expression of at least one additional sequence from the same protein and/or gene family as the target sequence.
Patent MX-2013013592-A (MX)
Title: Method for injection molding at low, substantially constant pressure.
Inventor: ALTONEN GENE MICHAEL
IPC: B29C45/78
Filed: 2012-05-21
Abstract: Injection molding methods at low, substantially constant melt pressures in particular a method comprising: (a) filling with a shot comprising a molten thermoplastic material an unpressurized mold cavity of a molding apparatus, the shot comprising the molten material having a melt pressure that, upon injection into the mold cavity, exceeds a pre-injection pressure of the shot comprising the molten material; and, (b) while filling substantially the entire mold cavity with the shot comprising the molten material, maintaining the melt pressure substantially constant at less than 6000 psi, wherein: an internal portion of the mold cavity spaced at least 2 mm from a most immediate surface of the mold cavity contacting the shot comprising the molten material is maintained at a temperature of less than about 100[deg.]C, and the thermoplastic material has a melt flow index of 0.1 g/10 min to about 500 g/10 min.
Patent MX-2013014692-A (MX)
Title: Method for increasing the massive production of conidia from the entomopathogenic fungus metarhizium anisopliae.
Inventor: GUZMAN JUAN CARLOS TORRES
IPC: C12N15/04
Filed: 2013-12-13
Abstract: The present invention refers to a method for obtaining Metarhizium anisopliae transformers, which are improved in their massive conidiation ability with a 3-23 times higher conidia production in plate or rice, in 5-8 days of incubation so as to be used as biological control agents of plague insects in agriculture, which are of important public health, by means of genetic engineering; the transformers are able to reduce or eliminate the messenger RNA of the CIE1 gene, which results in a higher yield in the production of conidia in a short incubation time, 5-8 days. These techniques allow any strain pertaining to the Metarhizium genus to be modified by means of genetic transformation in order to block the expression of the CIE1 genus. The transformation method involves the introduction of the antisense CIE1 genus of Metarhizium anisopliae, under the control of the suitable elements for regulating the expression, in one or more integrated copies in a stable manner in its genome. The amou nt of produced conidia is higher in the transformations compared to that of the wild strain used as genetic information receptor.
Patent MX-2014002924-A (MX)
Title: Completing a multi-stage well.
Inventor: LECERF BRUNO
IPC: E21B34/10
Filed: 2012-08-24
Abstract: A technique includes running a seat assembly on a conveyance line into a tubing string, which has previously been installed in a well. The seat assembly includes a seat, which is adapted to receive an untethered object. The technique includes attaching the seat assembly to the string at a location downhole in the well; receiving the object to create a fluid barrier; and diverting fluid using the fluid barrier.
Patent MX-2014005838-A (MX)
Title: Morpholinyl benzotriazine for use in cancer therapy.
Inventor: MEDERSKI WERNER
IPC: C07D471/04
Filed: 2012-10-30
Abstract: The invention relates to compounds of formula (I), where R1, L and m have the denotations as defined in the claims, and/or to the physiologically harmless salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios. The compounds of formula (I) can be used for inhibiting serine/threonine protein kinases and for sensitizing cancer cells to anticancer drugs and/or ionizing radiation. A further object of the invention is the use of the compounds of formula (I) in the prophylaxis, therapy or progress monitoring of cancers, tumors, metastases, or angiogenic disorders, in combination with radiotherapy and/or an anticancer drug. The invention further relates to a method for producing the compounds of formula (I) by reacting compounds of formulae (II) and (III) and, if need be, converting a chemical base or acid of the compounds of the formula (I) to one of the salts thereof.
Patent MX-2014005864-A (MX)
Title: System, apparatus and method for organizing and presenting offers through virtual channels.
Inventor: BJÖRK CHRISTER
IPC: G06Q30/02
Filed: 2012-11-14
Abstract: A sales offer organizing system comprising a content provider, a user terminal, and a server. The server is configured to receive a registration for at least one channel from said content provider, receive a subscription to said at least one channel from a user of said user terminal, receive a campaign associated with said channel from said content provider, said campaign comprising organization criteria, determine if said user is to be a recipient for the content based on the organization criteria, and if said user is a subscriber to said channel, and if so, send the campaign to said user terminal.